| AK | actinic keratosis |
| ALA | 5-aminolevulinic acid; naturally occurring precursor to protoprophyrin IX in the haem biosynthetic pathway |
| ALA-S | 5-aminolevulinic acid synthase, rate-limiting enzyme for haem synthesis |
| BCC | basal cell carcinoma |
| BD | bowen's disease |
| nBCC | nodular basal cell carcinoma |
| sBCC | superficial basal cell carcinoma |
| CR | complete response; complete disappearance of the treated lesion(s) |
| FD | fluorescence diagnosis |
| Fluorescence | luminescence that is caused by the absorption of radiation at one wavelength followed by nearly immediate reradiation usually at a different wavelength and that ceases almost at once when the incident radiation stops |
| MAL | methyl aminolevulinate |
| MAOP | Methyl-[5-amino-4-oxopentanoat]; German term for MAL |
| Non-CR | non-complete response, any less than complete disappearance of the treated lesion(s) |
| NMSC | non-melanoma skin cancer |
| PAP | photoactive porphyrins |
| PDD | photodynamic detection |
| PDT | photodynamic therapy |
| PpIX | photoporphyrin IX; a potent natural photosensitiser |
| ROS | reactive oxygen species; an excited or higher energy form of oxygen |
| SCC | squamous cell carcinoma |